A detailed history of Rhumbline Advisers transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 675,171 shares of TMO stock, worth $357 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
675,171
Previous 696,683 3.09%
Holding current value
$357 Million
Previous $385 Million 8.4%
% of portfolio
0.38%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$531.86 - $624.21 $11.4 Million - $13.4 Million
-21,512 Reduced 3.09%
675,171 $418 Million
Q2 2024

Aug 01, 2024

SELL
$541.52 - $599.02 $8.82 Million - $9.75 Million
-16,283 Reduced 2.28%
696,683 $385 Million
Q1 2024

May 09, 2024

BUY
$528.82 - $599.43 $217,873 - $246,965
412 Added 0.06%
712,966 $414 Million
Q4 2023

Feb 08, 2024

SELL
$431.41 - $532.94 $1.64 Million - $2.03 Million
-3,810 Reduced 0.53%
712,554 $378 Million
Q3 2023

Nov 09, 2023

BUY
$498.29 - $574.41 $1.29 Million - $1.49 Million
2,592 Added 0.36%
716,364 $363 Million
Q2 2023

Aug 08, 2023

BUY
$508.46 - $591.13 $7.23 Million - $8.41 Million
14,229 Added 2.03%
713,772 $372 Million
Q1 2023

May 11, 2023

BUY
$535.0 - $604.82 $5.28 Million - $5.97 Million
9,863 Added 1.43%
699,543 $403 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $14.8 Million - $17.4 Million
30,462 Added 4.62%
689,680 $380 Million
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $7.74 Million - $9.22 Million
15,258 Added 2.37%
659,218 $334 Million
Q2 2022

Aug 11, 2022

BUY
$500.9 - $612.21 $15.4 Million - $18.8 Million
30,674 Added 5.0%
643,960 $350 Million
Q1 2022

May 12, 2022

BUY
$524.0 - $644.92 $6.66 Million - $8.2 Million
12,712 Added 2.12%
613,286 $362 Million
Q4 2021

Feb 10, 2022

BUY
$569.0 - $667.24 $2.9 Million - $3.41 Million
5,105 Added 0.86%
600,574 $401 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $6.84 Million - $8.18 Million
-13,422 Reduced 2.2%
595,469 $340 Million
Q2 2021

Aug 05, 2021

SELL
$441.0 - $508.24 $14 Million - $16.1 Million
-31,721 Reduced 4.95%
608,891 $307 Million
Q1 2021

May 06, 2021

SELL
$439.85 - $518.83 $19.3 Million - $22.7 Million
-43,793 Reduced 6.4%
640,612 $292 Million
Q4 2020

Feb 10, 2021

SELL
$435.06 - $527.66 $2.75 Million - $3.34 Million
-6,331 Reduced 0.92%
684,405 $319 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $10.3 Million - $12.6 Million
28,506 Added 4.3%
690,736 $305 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $8.2 Million - $10.8 Million
29,799 Added 4.71%
662,230 $240 Million
Q1 2020

May 06, 2020

BUY
$255.3 - $340.05 $641,058 - $853,865
2,511 Added 0.4%
632,431 $179 Million
Q4 2019

Feb 05, 2020

SELL
$271.93 - $328.04 $326,859 - $394,304
-1,202 Reduced 0.19%
629,920 $205 Million
Q3 2019

Oct 23, 2019

BUY
$268.46 - $305.43 $2.21 Million - $2.52 Million
8,242 Added 1.32%
631,122 $184 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $2.91 Million - $3.34 Million
-11,308 Reduced 1.78%
622,880 $183 Million
Q1 2019

May 01, 2019

SELL
$212.17 - $273.72 $3.79 Million - $4.89 Million
-17,848 Reduced 2.74%
634,188 $174 Million
Q4 2018

Jan 31, 2019

BUY
$208.47 - $251.98 $1.65 Million - $1.99 Million
7,916 Added 1.23%
652,036 $146 Million
Q3 2018

Nov 07, 2018

SELL
$205.57 - $244.32 $1.87 Million - $2.22 Million
-9,090 Reduced 1.39%
644,120 $157 Million
Q2 2018

Aug 06, 2018

BUY
$203.14 - $219.53 $3.92 Million - $4.23 Million
19,282 Added 3.04%
653,210 $135 Million
Q1 2018

May 02, 2018

SELL
$192.98 - $224.11 $1.18 Million - $1.37 Million
-6,101 Reduced 0.95%
633,928 $131 Million
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $3.92 Million - $4.31 Million
21,515 Added 3.48%
640,029 $122 Million
Q3 2017

Nov 06, 2017

BUY
$171.74 - $194.04 $106 Million - $120 Million
618,514
618,514 $117 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.